Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Florbetapir PET in Changing Patient Management
NCT01703702Phase 4Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Oct 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of florbetapir (18F) in Alzheimer's disease (AD), sponsored by Avid Radiopharmaceuticals. Started Oct 2012; status: completed.
02
Drugs
florbetapir (18F)
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01703702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01703702.